Geographic Atrophy: The Advanced Form of Dry Age-Related Macular Degeneration

Webinar recorded June 28, 2022
Sponsored by Apellis Pharmaceuticals, Inc.

Over 1 million people in the United States are affected by a relentlessly progressive condition, known as Geographic Atrophy (GA), that can lead to irreversible vision loss with no current FDA-approved treatment options. This webinar focuses on GA - the advanced form of dry age-related macular degeneration (AMD) that is characterized by atrophic lesions in the central region of the macula. Join us to learn more about the prevalence, characteristics, and disease progression of GA.

©2022 Apellis Pharmaceuticals, Inc. All rights reserved. 07/22 US-GA-2200253 v1.0

Speaker:

Philip J. Ferrone, MD, FASRS
President, American Society of Retina Specialists
Attending physician, Vitreoretinal Consultants of New York
Professor of ophthalmology, Hofstra/Northwell
Adjunct assistant professor of ophthalmology, Columbia University

This webinar is sponsored, developed, and presented by the sponsor.  The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

©2022 Apellis Pharmaceuticals, Inc. All rights reserved. 07.22 US-GA-2200252 v1.0